title: Cerebral toxoplasmosis in a patient with common variable immunodeficiency.
authors.affiliation: Department of Neurology, University Hospital Charité, Schumannstr. 20/21, 10117 Berlin, Germany. martin.holtkamp@charite.de
authors.forename: Martin
authors.initials: M
authors.lastname: Holtkamp
authors.forename: Ali Fuat
authors.initials: AF
authors.lastname: Okuducu
authors.forename: Randolf
authors.initials: R
authors.lastname: Klingebiel
authors.forename: Christoph J
authors.initials: CJ
authors.lastname: Ploner
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications / Q000188:drug therapy; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001706:Biopsy; D001921:Brain / Q000469:parasitology / Q000473:pathology; D016543:Central Nervous System Neoplasms / Q000175:diagnosis; D017074:Common Variable Immunodeficiency / Q000150:complications*; D003680:Deglutition Disorders / Q000209:etiology; D003937:Diagnosis, Differential; D004401:Dysarthria / Q000209:etiology; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008223:Lymphoma / Q000175:diagnosis; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009894:Opportunistic Infections / Q000175:diagnosis / Q000209:etiology* / Q000469:parasitology; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011782:Quadriplegia / Q000209:etiology; D013411:Sulfadiazine / Q000627:therapeutic use; D016781:Toxoplasmosis, Cerebral / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D007166:Immunosuppressive Agents; D013411:Sulfadiazine; D011239:Prednisolone; D011739:Pyrimethamine